Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2010
02/04/2010US20100028366 Synergistic effect between a cyanogenic system and another oxidative inducing system for treating tumors
02/04/2010US20100028365 Methods and compositions for the diagnosis and treatment of cancer
02/04/2010US20100028360 Methods for the modulation of brain progestagen signaling in the prevention and treatment of neurological disorders and neurodegenerative diseases
02/04/2010US20100028359 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
02/04/2010US20100028352 COMPOSITIONS AND METHODS COMPRISING GLYCYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
02/04/2010US20100028351 Anti-amyloid antibodies, compositions, methods and uses
02/04/2010US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
02/04/2010US20100028347 Antibodies against vascular endothelial growth factor receptor-1
02/04/2010US20100028344 Conditioned cell immunization
02/04/2010US20100028343 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein
02/04/2010US20100028341 Amino acid sequences that modulate the interaction between cells of the immune system
02/04/2010US20100028340 Antibodies against the rgm a protein and uses thereof
02/04/2010US20100028336 Anti-Mesothelin Antibodies
02/04/2010US20100028330 Methods of upmodulating adaptive immune response using anti-pd1 antibodies
02/04/2010US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/04/2010US20100028310 Composition for Transplantation Comprising Adipose Stem Cells or Adipocytes
02/04/2010US20100028308 Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
02/04/2010US20100028306 Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof
02/04/2010US20100028305 Methods for the treatment of lysosomal storage disorders
02/04/2010US20100028263 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus
02/04/2010US20100028256 Differential gene expression in physiological and pathological angiogenesis
02/04/2010CA2732721A1 Melk epitope peptides and vaccines containing the same
02/04/2010CA2732401A1 Efficient method for establishing induced pluripotent stem cells
02/04/2010CA2732025A1 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby
02/04/2010CA2731038A1 Plants having modified growth characteristics and a method for making the same
02/04/2010CA2697621A1 Method of efficiently establishing induced pluripotent stem cells
02/03/2010EP2149604A1 Collections of repeat proteins comprising repeat modules
02/03/2010EP2149602A1 Method for concentration of side population cell fraction
02/03/2010EP2149601A1 Composition of solubilized amnion and use thereof
02/03/2010EP2149382A1 Dentinogenesis promoter and dentinogenic pulp-capping material
02/03/2010EP2149381A2 Method of treating malignancies through induction of blood immune responses
02/03/2010EP2148924A1 Nucleic acid molecules coding for a protein with deacetylase activity, said protein, and method for the production of chitosan
02/03/2010EP2148923A1 Preservation of bioactive materials by freeze dried foam
02/03/2010EP2148887A2 Oriented collagen-based materials, films and methods of making same
02/03/2010EP2148569A1 Methods and compositions for stem cell self-renewal
02/03/2010CN101641436A Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)
02/03/2010CN101641435A Processes of producing fermentation products
02/03/2010CN101638437A Growth hormone fusion protein
02/03/2010CN100587068C Use of multiple recombination sites with unique specificity in recombinational cloning
02/03/2010CN100587062C Method for separating and purifying mitochondrion from pear pollen tube
02/02/2010US7655847 Plants and seeds of hybrid corn variety CH652087
02/02/2010US7655846 Plants and seeds of hybrid corn variety CH234162
02/02/2010US7655840 Alteration of embryo/endosperm size during seed development
02/02/2010US7655837 Glutathione-S-transferase gene from Proposis juliflora confers abiotic stress tolerance in plants
02/02/2010US7655836 Using expression vector comprising nucleotide sequences coding sucrose isomerase as tool in generating transgenic plants with increased carbohydrate concentration; for use in fermenting compounds such as methanol, ethanol and 1,3 propandiol
02/02/2010US7655834 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector
02/02/2010US7655783 Methods and compositions for increasing antibody production
02/02/2010US7655779 Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences
02/02/2010US7655778 SISP-1, a novel p53 target gene and use thereof
02/02/2010US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
02/02/2010US7655760 Antibodies to the polypeptide hormone phosphatonin
02/02/2010US7655635 Suppression of nuclear factor-κB dependent processes using oligonucleotides
02/02/2010US7655634 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
02/02/2010US7655469 Nucleic acid molecules and other molecules associated with the cytokinin pathway
02/02/2010US7655465 Also melanocyte stem cells and to their use in cell replacement therapies including skin grafts, hair transplantation strategies, and tissue engineering
02/02/2010US7655464 Dual inhibitors of HIV-1 GP-120 interactions
02/02/2010US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase
02/02/2010US7655462 Anti-tumor activity of Ea-4-peptide of pro-IGF-I
02/02/2010US7655461 Nucleic acid encoding a receptor other than an immunoglobulin, wherein the receptor binds to a MUC 1 tumor antigen independently of a major histocompatibility complex (MHC); activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor
02/02/2010US7655460 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins with mutations associated with epilepsy
02/02/2010US7655458 Endostatin for use in the treatment of cancer and tumor metastasis
02/02/2010US7655449 β-fructofuranosidase variants
02/02/2010US7655441 Nucleic acid sequences having gene transcription regulatory qualities
02/02/2010US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES
02/02/2010US7655422 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners
02/02/2010US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues
02/02/2010US7655406 Expression vector comprising nucleotide sequences coding non-structural proteins of hepatitis virus for use in identifying modulators which prevent viral infections
02/02/2010US7655393 Adoptive immune cells for tumor vaccines
02/02/2010US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
02/02/2010US7655246 Chlamydia protein, gene sequence and uses thereof
02/02/2010US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders
02/02/2010US7655234 Inhibiting growth of a solid tumor cell that expresses the protein; cancer diagnosis
02/02/2010US7655225 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
02/02/2010US7655224 Neural stem cells and use thereof for brain tumor therapy
02/02/2010US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
02/02/2010CA2459489C Method for diagnosing or monitoring carbohydrate metabolism disorders
02/02/2010CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics
02/02/2010CA2427029C Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
02/02/2010CA2355893C Antiuracil monoclonal antibody
02/02/2010CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
02/02/2010CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3
02/02/2010CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis
02/02/2010CA2186607C Plant lysophosphatidic acid acyltransferases
02/02/2010CA2160937C Survival motor neuron (smn) gene: a gene for spinal muscular atrophy
02/02/2010CA2146974C Direct selection of cells by secretion product
01/2010
01/28/2010WO2010011766A1 Automated system for cryopreservation of oocytes, embryos, or blastocysts
01/28/2010WO2010011717A2 Propagation of switchgrass and miscanthus
01/28/2010WO2010011644A2 Differentiated anucleated cells and method for preparing the same
01/28/2010WO2010011352A2 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use
01/28/2010WO2010011161A1 Method for producing live cell vaccine for preventing mammary cancer
01/28/2010WO2010010887A1 Tissue expression promoter
01/28/2010WO2010010848A1 Method for production of antibody in cultured mammalian cell by using molecular chaperone
01/28/2010WO2010010178A1 The tuberculosis rv2707c protein, compositions and uses thereof
01/28/2010WO2010009905A1 Cancer treatment and test
01/28/2010WO2009126789A3 Engineering and delivery of therapeutic compositions of freshly isolated cells
01/28/2010WO2009079606A3 Microrna-induced es-like cells and uses thereof
01/28/2010WO2008120201A3 An isolated population of cells and methods of generating and using same
01/28/2010WO2004001003A9 Plastid division and related genes and proteins, and methods of use
01/28/2010US20100024081 Somatic embryogenesis and embryo harvesting and method and apparatus for preparing plant embryos for plant production
01/28/2010US20100024074 Arabidopsis derived promoters for regulation of plant expression